LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Alvocidib | 0.12 | uM | LJP6 | 3 | A17 | 72 | hr | 1097 | 622 | 3696 | 0.1683 | -0.2767 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1209 | 1710 | 4121 | 0.4149 | 0.2163 |
| Hs 578T | Dovitinib | 10 | uM | LJP5 | 3 | E19 | 72 | hr | 658 | 907 | 3938 | 0.2303 | 0.1323 |
| Hs 578T | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 658 | 3408 | 3938 | 0.8653 | 0.8910 |
| BT-20 | Alvocidib | 0.04 | uM | LJP6 | 3 | A18 | 72 | hr | 1097 | 981 | 3696 | 0.2654 | -0.0619 |
| MCF7 | WZ3105 | 3.33 | uM | LJP5 | 3 | D20 | 72 | hr | 1209 | 663 | 4376 | 0.1515 | -0.2768 |